Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

PLGA-based microneedles show promise for painless, long-term drug delivery but need design and safety improvements.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Stimulating sensory neurons can increase IGF-I production, which may help treat various diseases and improve tissue health.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Targeting LPA could help treat skin disorders.

PGF_2α receptors in human eyelids are found in specific parts of hair follicles, explaining eyelash changes with glaucoma treatment.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.